Special: ASH 2018
Released: Dec 8, 2018
In this special edition of the MDedge Daily News, MDedge Hematology Editor, Mary Ellen Schneider, and Nick Andrews present some of the most important news with full comments from researchers and clinicians.
CLL resistance mechanism to venetoclax identified.
http://bit.ly/2RR6qB6 Rivaroxaban may reduce VTE risk in cancer patients.
http://bit.ly/2QiIhaf New treatments promise sickle cell "cure" for all ages.
http://bit.ly/2EaZL0X Gut bacteria influence HCT outcomes.
http://bit.ly/2PrpzYH
